Single agent ONC201 in adult recurrent H3 K27M-mutant glioma.

Isabel Arrillaga,Sylvia Kurz,Ashley Sumrall,Nicholas Butowski,Rebecca Harrison,John Frederick de Groot,Nicole Shonka,Frank Lieberman,Yazmin Odia,Rohinton Tarapore,Krystal Merdinger,Joshua E. Allen,Wolfgang Oster,Minesh P. Mehta,Timothy F. Cloughesy,Andrew S. Chi,Andrew B. Lassman,Tracy T. Batchelor,Patrick Y. Wen

Single agent ONC201 in adult recurrent H3 K27M-mutant glioma.

2019

Isabel Arrillaga
Sylvia Kurz
Ashley Sumrall
Nicholas Butowski
Rebecca Harrison
John Frederick de Groot
Nicole Shonka
Frank Lieberman
Yazmin Odia
Rohinton Tarapore
Krystal Merdinger
Joshua E. Allen
Wolfgang Oster
Minesh P. Mehta
Timothy F. Cloughesy
Andrew S. Chi
Andrew B. Lassman
Tracy T. Batchelor
Patrick Y. Wen

3005Background: H3 K27M-mutant glioma is associated with a poor prognosis and there is no effective therapy following radiation. We report the clinical experience with single agent ONC201, the firs...

Keywords:

Glioma
Pathology
Mutant
Medicine
single agent
Cancer research
poor prognosis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations